18 November 2020, 10AM CET (9AM GMT).
To register and further information on the programme and speakers, go to the event’s Eventbrite page.
About this Event
Novel approaches to distinguishing bacterial from viral infections: lessons learnt from PERFORM and next steps in DIAMONDS.
Consortia from two European Commission’s Horizon2020 program projects are presenting in this joint seminar to present the main results of one research project, (PERFORM) and the next steps with its sister project, DIAMONDS. PERFORM (PErsonalised Risk assessment in Febrile illness to Optimise Real-life Management across the European Union) aims to improve the diagnosis and management of fever in children by developing simple personalized tests to distinguish between bacterial and viral infection using transcriptomic and proteomic biomarkers, and identifying the best management strategies for using these new tests in the varied healthcare settings of Europe. DIAMONDS (DIAgnosis and Management Of Febrile Illness using RNA Personalised Molecular Signature DiagnosiS) is taking this research further through existing devices and new prototypes via an innovative approach called Personalised Molecular Signature Diagnosis (PMSD).
In this session we will hear from many of the partners in both consortia, followed by a plenary discussion.
TIME: 10:00AM – 12:30PM (CET)
9:00AM – 11:30PM (GMT)
- Aims of PERFORM and why we need better diagnostic approaches to identifying bacterial infection
Prof. Mike Levin, Imperial College London (UK)
- The PERFORM Clinical Cohort: a multi-country prospective hospital cohort for study of febrile children
Prof. Federico Martinón-Torres, Servizo Galego de Saude (Spain)
- Emergency care in febrile children in Europe: the MOFICHE study
Prof. Dr. Henriëtte Moll, Erasmus Universitair Medisch Centrum Rotterdam (The Netherlands)
- How molecular pathogen detection in blood and respiratory mucosa is changing our perspective of the bacterial/viral paradigm
Prof. Colin Fink & Dr Marie Ann Voice, Micropathology (UK)
- Identifying host blood RNA biomarker signatures to diagnose bacterial infection
Dr. Myrsini Kaforou, Imperial College London (UK)
- Identifying plasma protein biomarkers to distinguish bacterial and viral infection
Prof. Taco Kuijpers, Academic Medical Center Amsterdam (The Netherlands)
- Translation of host biomarkers into a diagnostic test
Dr. François Mallet, bioMérieux (France)
- Cost and social factors in the introduction of a test
Prof. Shunmay Yeung, The London School of Hygiene & Tropical Medicine (UK)
Plenary discussion moderated by Prof. Mike Levin